Bezitramide: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoB |
Fixed spacing between stub template and category templates. |
||
(55 intermediate revisions by 39 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Opioid analgesic drug}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = 447617484 |
||
| IUPAC_name = 4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1''H''-benzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile |
| IUPAC_name = 4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1''H''-benzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile |
||
| image = Bezitramide.svg |
| image = Bezitramide.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = |
| legal_AU = |
||
| |
| legal_BR = A1 |
||
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-04-04}}</ref> |
|||
| legal_CA = Schedule I |
|||
| legal_US = Schedule II |
|||
| legal_DE = Anlage I |
|||
| routes_of_administration = Oral |
| routes_of_administration = Oral |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| metabolism = |
| metabolism = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CASNo_Ref = {{cascite|??|??}} |
|||
| CAS_number = 15301-48-1 |
| CAS_number = 15301-48-1 |
||
| ATC_prefix = N02 |
| ATC_prefix = N02 |
||
Line 24: | Line 25: | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = DB01459 |
| DrugBank = DB01459 |
||
| KEGG = D07289 |
|||
| ChEMBL = 2104149 |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 55675 |
| ChemSpiderID = 55675 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = 3KXW0Y310I |
| UNII = 3KXW0Y310I |
||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=31 | H=32 |
| C=31 | H=32 |
||
| N=4 | O=2 |
|||
| molecular_weight = 492.611 g/mol |
|||
| smiles = O=C(N2c1ccccc1N(C2=O)C5CCN(CCC(C#N)(c3ccccc3)c4ccccc4)CC5)CC |
| smiles = O=C(N2c1ccccc1N(C2=O)C5CCN(CCC(C#N)(c3ccccc3)c4ccccc4)CC5)CC |
||
| InChI = 1/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3 |
|||
| InChIKey = FLKWNFFCSSJANB-UHFFFAOYAZ |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3 |
| StdInChI = 1S/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3 |
||
Line 40: | Line 40: | ||
| StdInChIKey = FLKWNFFCSSJANB-UHFFFAOYSA-N |
| StdInChIKey = FLKWNFFCSSJANB-UHFFFAOYSA-N |
||
}} |
}} |
||
'''Bezitramide''' is a narcotic [[analgesic]]. Bezitramide itself is a [[prodrug]] which is readily [[Hydrolysis|hydrolyzed]] in the [[gastrointestinal tract]] to its main [[metabolite]], despropionyl-bezitramide. Bezitramide was discovered at [[Janssen Pharmaceutica]] in 1961<ref>{{ cite patent |
|||
| country = US |
|||
| number = 3196157 |
|||
| status = patent |
|||
| title = BENZIMIDAZOLINYL PIPERIDINES |
|||
| pubdate = 1963-06-11 |
|||
| gdate = 1965-07-20 |
|||
| inventor = Paul A. J. Janssen. |
|||
}}</ref>. It is most commonly marketed under the trade name Burgodin. |
|||
'''Bezitramide''' is an opioid [[analgesic]]. Bezitramide itself is a [[prodrug]] which is readily [[Hydrolysis|hydrolyzed]] in the [[gastrointestinal tract]] to its [[active metabolite]], despropionyl-bezitramide.<ref>{{cite journal | vauthors = Meijer DK, Hovinga G, Versluis A, Bröring J, van Aken K, Moolenaar F, Wesseling H | title = Pharmacokinetics of the oral narcotic analgesic bezitramide and preliminary observations on its effect on experimentally induced pain | journal = European Journal of Clinical Pharmacology | volume = 27 | issue = 5 | pages = 615–8 | year = 1984 | pmid = 6519169 | doi = 10.1007/BF00556902 | s2cid = 23978449 }}</ref> Bezitramide was discovered at [[Janssen Pharmaceutica]] in 1961.<ref>{{ cite patent | country = US | number = 3196157 | status = patent | title = Benzimidalinyl Piperidines | pubdate = 1963-06-11 | gdate = 1965-07-20 | inventor = Janssen PA }}</ref><ref>{{cite journal | vauthors = Janssen PA, Niemegeers CJ, Schellekens KH, Marsboom RH, Herin VV, Amery WK, Admiraal PV, Bosker JT, Crul JF, Pearce C, Zegveld C | display-authors = 6 | title = Bezitramide (R 4845), a new potent and orally long-acting analgesic compound | journal = Arzneimittel-Forschung | volume = 21 | issue = 6 | pages = 862–7 | date = June 1971 | pmid = 5109278 }}</ref><ref>{{cite journal | vauthors = Knape H | title = Bezitramide, an orally active analgesic. An investigation on pain following operations for lumbar disc protrusion (preliminary report) | journal = British Journal of Anaesthesia | volume = 42 | issue = 4 | pages = 325–8 | date = April 1970 | pmid = 4913411 | doi = 10.1093/bja/42.4.325 | doi-access = free }}</ref> It is most commonly marketed under the trade name '''Burgodin'''. |
|||
⚫ | |||
⚫ | The drug was pulled from the shelves in the [[Netherlands]] in 2004 after fatal overdose cases, including one where a five-year-old child took one tablet from his mother's purse, ate it, and promptly died.<ref>{{cite journal | vauthors = de Vos JC, Rohof OJ, Bernsen PJ, Conemans JM, van Unnik AJ | title = [Death caused by one tablet of Burgodin] | journal = Nederlands Tijdschrift voor Geneeskunde | volume = 127 | issue = 34 | pages = 1552–3 | date = August 1983 | pmid = 6633692 }}</ref> |
||
Bezitramide is regulated much the same as [[morphine]] in all known jurisdictions and is, surprisingly, a [[Controlled Substances Act |Schedule II]] rather than Schedule I [[narcotic]] under the United States' Controlled Substances Act of 1970. However, it has to this point never been marketed in the United States. |
|||
Bezitramide is regulated much the same as [[morphine]] in all known jurisdictions and is a [[Controlled Substances Act|Schedule II]] substance under the United States' Controlled Substances Act of 1970, with an ACSCN of 9800 and zero annual manufacturing quota.<ref>{{Cite web |url=http://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm |title=Title 21 United States Code (USC) Controlled Substances Act |access-date=2011-09-29 |archive-date=2020-08-30 |archive-url=https://web.archive.org/web/20200830032541/https://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm |url-status=dead }}</ref> However, as of May 2021, it has never been marketed in the United States. |
|||
Other drugs which are legal for medical use in the US but not marketed up to this point in time include [[phenazocine]], [[metopon]], [[alphaprodine]] (formerly marketed as Nisentil) , [[anileridine]] (formerly marketed as Leritine), [[ethylmorphine]] (regulated like codeine and therefore preparations with other active ingredients can be Schedule III or Schedule V), [[isomethadone]], [[levomethorphan]], [[metazocine]], [[piminodine]] (formerly marketed as Alvodine), [[racemethorphan]], [[moramide intermediate]] (the most common moramide, the Schedule I [[dextromoramide]] was once marketed in the US as Dimorlin for a short time in the 1950s), and [[racemorphan]]. <!--The previous paragraph has almost nothing to do with Bezitramide. It doesn't belong on this page--> |
|||
==See also== |
|||
* [[Benperidol]] |
|||
* [[Brorphine]] |
|||
* [[J-113,397]] |
|||
==References== |
== References == |
||
{{Reflist|2}} |
|||
* Knape H., Bezitramide, an orally active analgesic. An investigation on pain following operations for lumbar disc protrusion (preliminary report), Br J Anaesth. 1970 Apr;42(4):325-8. |
|||
{{Analgesics}} |
|||
* Janssen PA, Niemegeers CJ, Schellekens KH, Marsboom RH, Herin VV, Amery WK, Admiraal PV, Bosker JT, Crul JF, Pearce C, Zegveld C., Bezitramide (R 4845), a new potent and orally long-acting analgesic compound, Arzneimittelforschung. 1971 Jun;21(6):862-7. |
|||
{{Opioidergics}} |
|||
* de Vos JC, Rohof OJ, Bernsen PJ, Conemans JM, van Unnik AJ. Death caused by one tablet of Burgodin. (Dutch). Nederlands Tijdschrift voor Geneeskunde. 1983 Aug 20;127(34):1552-3. PMID: 6633692 |
|||
[[Category:Synthetic opioids]] |
[[Category:Synthetic opioids]] |
||
Line 69: | Line 64: | ||
[[Category:Ureas]] |
[[Category:Ureas]] |
||
[[Category:Propionamides]] |
[[Category:Propionamides]] |
||
[[Category:Mu-opioid agonists]] |
[[Category:Mu-opioid receptor agonists]] |
||
[[Category:Janssen Pharmaceutica]] |
[[Category:Janssen Pharmaceutica]] |
||
[[Category:Belgian inventions]] |
|||
⚫ | |||
⚫ | |||
[[ru:Безитрамид]] |
|||
[[sv:Besitramid]] |